Kristin Myers Joins Northwell As 1st Chief Digital Officer | Recognized by Crain’s NY & Becker’s Hospital Review

Kristin Myers

Northwell Health is proud to announce that Kristin Myers has joined the health system as its first-ever executive vice president and chief digital officer. Ms. Myers will be leading and transforming Northwell’s digital services to improve patient care.

Background

Myers comes to Northwell from Mount Sinai Health System, where she served as executive vice president, chief digital and information officer, and dean for digital and information technology. She has extensive experience driving organizational change, adopting cutting-edge technologies, enabling digital transformation, modernizing and streamlining the technology landscape, and much more.

Myers Comments

“I’m so excited to be joining the team at Northwell Health,” Kristen Myers said. “The focus on patients at Northwell, and the health system’s commitment to technology and innovation, really make it stand out. We’re going to use technology to improve the experience and change the way care is delivered to our patients.”

During her career, Ms. Myers has earned many accolades for her work, including recognition by Crain’s New York Business’ 2023 Notable Health Care Leaders, Becker’s Hospital Review’s Hospital and Health System CIOs to Know 2023, Becker’s Hospital Review’s 35 Hospital and Health System Chief Digital Officers to Know 2023, and as a nominee of the 2022 New York CIO of the Year ORBIE Awards. She holds an Executive Master of Public Health from Columbia University and an Executive Chief Information Security Officer certification from Carnegie Mellon.

Joseph Moscola, PA-C, MBA Northwell’s EVP for Enterprise Services Notes:

“We are thrilled to be adding Kristin to our leadership team as we continue on our digital transformation journey. Her experience, leadership, and vision will accelerate our health and harmony journey for our customers and our Northwell team members.”

As the chief digital officer, Ms. Myers will be driving Northwell’s digital transformation. The health system will be using technology to change the way the patient experience is designed and also to streamline systems that team members use every day.

As part of the health system’s ongoing digital transformation, Northwell announced that it selected Epic, the industry-leading electronic health record (EHR) to ensure a more seamless patient experience, including one patient record across all Northwell venues of care. Northwell is also utilizing Google Cloud to uncover data insights to create a more personalized patient experience.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.